With regard to molecular mechanisms, some miR-125a targets have been validated in HCC cells, such as matrix metalloproteinase-11 (MMP11), sirtuin-7 (SIRT-7), Zbtb7a, and the stemness factor Lin28b [16,21,22,23,24,25]. This evidence concerns the gene MMP11 and hepatocellular carcinoma.